Home › Heart Failure › California › Mountain View
Heart Failure clinical trials in Mountain View, CA
15 studies for Heart Failure are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ELEVATE-HFpEF Clinical Study
Recruiting
- Stanford University, Palo Alto · 5 mi away
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RecruitingPhase 3
- Research Site, Palo Alto · 5 mi away
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecruitingPhase 3
- Stanford University Hospital / Stanford Health Care, Stanford · 5 mi away
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingPhase 2/3
- Lucile Packard Children's Hospital ( Site 0040), Palo Alto · 5 mi away
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
RecruitingObservational study
- Research Site, Palo Alto · 5 mi away
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Lucile Packard Children's Hospital, Palo Alto · 5 mi away
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- Stanford, Stanford · 5 mi away
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- Stanford Health Care Hospital & Clinics, Palo Alto · 5 mi away
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RecruitingPhase 3
- Tenax Investigational Site, Stanford · 5 mi away
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Recruiting
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto · 5 mi away
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
RecruitingObservational study
- Stanford University, Palo Alto · 5 mi away
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RecruitingPhase 2
- Lucile Packard Children's Hospital, Palo Alto · 5 mi away
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
RecruitingPhase 3
- Stanford University Medical Center, Stanford · 5 mi away
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Recruiting
- Stanford University, Stanford · 5 mi away
Identifying Markers of Exercise Training in Heart Failure
Recruiting
- Stanford Health Care, Stanford · 5 mi away
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer25 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Prostate Cancer15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
- Colorectal Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.